Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors

Bone Marrow Transplantation
L S LambR S Parrish

Abstract

Myeloablative chemotherapy followed by transplantation of a T cell-depleted bone marrow graft from a partially mismatched related donor provides a potentially curative option for patients with leukemia and other disorders of hematopoiesis, although the patient is faced with a period of sustained immunodeficiency as well as pharmacologic immunosuppression as a result of prophylaxis against graft-versus-host disease. Thirty patients who received one to three antigen T cell-depleted mismatched grafts were evaluated for immune reconstitution. The percentage and numbers of cells expressing lymphocyte subset antigens were determined by flow cytometry at 14, 28, 60, 100, 180, 270 and 365 days post-BMT and at 6 month intervals thereafter. Lymphocyte reconstitution was characterized by the early appearance of natural killer cells and a low percentage of both T and B cells. During the first year after BMT, the number of NK cells remained constant while T and B cells gradually returned to normal numbers and proportions. Response to the lymphocyte mitogen phytohemagglutinin returned to normal over the course of 2 years, while the response to concanavalin A was slightly depressed and the response to pokeweed mitogen became supranormal at ab...Continue Reading

Citations

Nov 15, 2002·International Journal of Hematology·Michael E Trigg
Sep 21, 2004·Springer Seminars in Immunopathology·Franco Aversa, Massimo F Martelli
Jun 23, 2001·Toxicology·UNKNOWN Immunotoxicology Technical Committee, International Life Sciences Institute and Environmental Sciences Institute
Mar 22, 2005·Bone Marrow Transplantation·J J Auletta, H M Lazarus
Jul 27, 2001·British Journal of Haematology·M W LowdellH G Prentice
Jun 3, 1999·The New England Journal of Medicine·E C GuinanJ G Gribben
Jul 14, 2000·Journal of Hematotherapy & Stem Cell Research·J S Bryson, D L Flanagan
Apr 2, 2002·Best Practice & Research. Clinical Haematology·P J Henslee-Downey
Nov 30, 1999·Hematology/oncology Clinics of North America·P J Henslee-Downey, E Gluckman
Jul 4, 2002·Hematology/oncology Clinics of North America·Lawrence S Lamb
Jan 1, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephan A GruppLaurence J N Cooper
Oct 5, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ulas D BayraktarStefan O Ciurea
Sep 25, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·A K KleinN J Chao
Sep 12, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Joanne Filicko-O'HaraNeal Flomenberg
Jan 2, 2009·Journal of Hematology & Oncology·Xiao-jun Huang
Mar 29, 2014·Frontiers in Immunology·Salem ChouaibJan Spanholtz
Nov 7, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hiroyasu OgawaIchiro Kawase
Jan 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael R Verneris, Stephan A Grupp
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William G WoodsBeverly J Lange
Oct 18, 2000·Bone Marrow Transplantation·S M BarryG Janossy
May 22, 2001·Bone Marrow Transplantation·J M Rowe, H M Lazarus
Mar 16, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Charles T LutzSteven R Presnell
Nov 25, 2003·Hematology·Ghulam MuftiAloysius Y L Ho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

© 2022 Meta ULC. All rights reserved